MedPath

Effects of anti diabetic drug Metformin in type 2 diabetes mellitus who are not obese

Not Applicable
Conditions
Health Condition 1: null- diabetes
Registration Number
CTRI/2013/06/003787
Lead Sponsor
nil
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

1)Individuals should have type 2 Diabetes Mellitus

2)Duration of disease less than 5 years

3)Body mass index less than 23 kg per meter square

4)Glycosylated Hemoglobin more than 7%

5)Fasting plasma glucose more than 140 mg/dl

6)Post prandial sugar more than 200 mg/dl

Exclusion Criteria

1)Age less than 18 years and more than 65 years

2)Duration of Diabetes Mellitus more than 5 years

3)Body mass index more than 23 kg per meter square

4)Glycosylated Hemoglobin less than 7% and more than 10 %

5)Fasting plasma glucose less than 140 and more than 200 mg/dl

6)Post prandial sugar less than 200 mg/dl and more than 300 mg/dl

7)Serum creatinine more than 1.4 mg/dl in females and more than 1.5 mg/dl in males or urine albumin more than 300 mg/ 24 hours

8)Patients with acute or chronic liver disease

9)Patients with secondary cause for diabetes

10)Patients who are on drugs which can affects the glucose homeostasis

11)Pregnant and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath